Thomas Preining and Aycancan Guven led a 1-2 for Manthey EMA during official pre-season testing for DTM at Oschersleben. Just a single day of official collective testing was available for DTM teams ...

MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, ...

The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of ...

More ‘biosimilar’ medicines should be brought to market in the EU because of a regulatory policy shift on the need to carry out expensive clinical efficacy studies, experts have said.

A cancer patient who needed €300,000 in fundraising to have vital treatment in London has joined forces with other advocates ...

The European Medicines Agency (EMA) announced it is exploring improvements to the development and evaluation of biosimilar ...

Roberta Cannella, Chief Technical Officer, commented: "This submission brings us closer to offering patients a new option for AKYNZEO ®. It not only demonstrates our commitment to enhancing patients' ...

USD/JPY and AUD/USD trends influenced by Trump’s tariff actions, U.S. jobs data, and central bank outlooks. Market sentiment ...

“The rupee has benefited from a recent weakness in the dollar and the Reserve Bank of India allowing for a two-way movement, but key risks to India's external sector balance continue to stem from the ...

The pandemic showed just what can be achieved with faster and more efficient regulatory approval — the same approach needs to be applied now to save patients’ lives and tackle the growing burden ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...